Clinical Trial Update: Gastroenteritis From Rotavirus Infection in Brazilian Children Less Than 5 Years of Age (Study V260-031).

View source ↗

Summary

Clinical trial V260-031 evaluating rotavirus-associated gastroenteritis in Brazilian children under 5 was terminated, with results posted in December 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotaviral Gastroenteritis

Drugs mentioned

• RotaTeq (rotavirus vaccine, pentavalent)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Pediatric Gastroenteritis | Status: TERMINATED | Results posted: 2012-12-05